Back to Authors

Cerhan, James R.

https://orcid.org/0000-0002-7482-178X

A5076621021 | I1330342723

Mayo Clinic

Citations 708

Chronic Lymphocytic Leukemia in African Ancestry Population Is Characterized By Increased Telomere Erosion

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4135-4136

10.1182/blood-2022-170944

Predictive Value of Staging PET/CT to Detect Bone Marrow Involvement in Marginal Zone Lymphoma (MZL): An Analysis from LEO MZL Working Group

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9340-9341

10.1182/blood-2022-162688

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1307-1309

10.1182/blood-2022-167466

Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2056-2058

10.1182/blood-2022-169433

Molecular Landscape of Primary Refractory DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223

10.1182/blood-2022-156497

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644

10.1182/blood-2022-157083

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744

10.1182/blood-2022-159620

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6489-6491

10.1182/blood-2022-167633

Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphomas: The Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (LEO-MER) Prospective Cohort Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3666-3668

10.1182/blood-2022-164988

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6426-6427

10.1182/blood-2022-160351